Health Care: Drugs

Pharmacyclics Inc (PCYC: NASDAQ)

$256.37 -0.28 | -0.11%
03/26/15 - 04:14 PM ET
Company Profile
Price and Volume
Recent Price 256.65
52 Week High 258.95
52 Week Low 82.51
Avg. Daily Vol. (Mil) 1.64
Beta (3 year) 0.74
Share Related Items
Mkt Cap (Mil) 19,509.74
Shares Out (Mil) 76.02
Float (Mil) 44.50
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 4.90
Current Ratio 5.20
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings 232.90
Price/Sales 26.74
Price/Book 23.53
Price/Cash Flow 215.50
Per Share Data
Earnings 1.10
Sales 9.60
Book Value 10.91
Cash Flow 1.19
Business Summary
Pharmacyclics Inc is a biopharmaceutical companyengaged in developing and commercializing novel therapies for the treatment of cancer and immune-mediated diseases.
General Information
995 East Arques Avenue
Sunnyvale, CA 94085-4521
www.pharmacyclics.com
Industry : Drugs
Sector: Health Care
Employees: 607
CEO: Robert W. Duggan
Short Interest
Current Month (Mil) 2.60
Previous Month (Mil) 5.25
Short Interest Ratio (Days) 0.90
Management Effectiveness
Return on Equity 10.40
Return on Assets 8.10
Return on Investments 10.40
Profitability
Gross Margin 64.00
EBIT Margin 16.80
Profit Margin 11.80

Portfolios with PCYC

Latest PCYC Headlines from TheStreet

More Financial News for PCYC

Press Releases for PCYC

See All Press Releases

Partner Headlines for PCYC

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter